agreed to drop its infringement lawsuit over Moderna Inc.'s Covid-19 vaccine after a federal judge's unfavorable patent ruling last week, even as their more recent related case will continue. Alnylam determined that the court's definitions of three disputed constructions affecting all asserted ...
Moderna wins Covid jab patent dispute over Pfizer and BioNTech Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals Save April 22 2024 News in-depthCovid-19 vaccines Covid vaccine makers to clash in London over mRNA patent dispute Moderna...
Here's when you're most likely to spread COVID, flu, RSVAre flu and COVID high now? Here's how the season has startedMany more seniors are getting COVID shots this year, CDC reportsCDC recommends 2nd dose of this year's COVID shot for those age 65+FDA authorizes over-the-counter ...
Buoyed by the success of its COVID-19 vaccine, Moderna has started a phase 1/2 trials of its mRNA-based shot for seasonal influenza, targeting four different flu strains. The first patents have now been enrolled into the study of the shot – codenamed m